These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Raymond James Financial Inc. purchased a new position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free ...

We recently published a list of 15 Cheapest Stocks Insiders Are Buying In March. In this article, we are going to take a look ...

Shanghai Henlius Biotech and Organon (OGN) announced that the European Medicines Agency has validated the marketing authorization application ...

Northwest Biotherapeutics Inc. can proceed with claims against seven firms including Citadel Securities and Virtu Americas LLC for depressing the company’s stock price through false sale orders, a ...

PTC Therapeutics' Translarna loses EU conditional approval, but countries may allow continued use. PTC submitted four FDA ...

Vaxart (NASDAQ:VXRT – Get Free Report) had its price target decreased by stock analysts at B. Riley from $2.50 to $2.00 in a ...

Live updates on stocks, bonds and markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Learn more about whether Alvotech or Vericel Corporation is a better investment based on AAII's A+ Investor grades, which ...

Learn more about whether Alvotech or Protagonist Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades ...

Sensei Biotherapeutics' solnerstotug shows a 14% ORR in PD-(L)1 resistant tumors and remains well tolerated in early trial data from its Phase 1/2 study.

A Durham company is pushing back on media reports questioning the safety of its lead product as the firm begins its commercial launch.